HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E

por Chang, Xiaoyu, Zhang, Tianshun, Wang, Qiushi, Rathore, Moeez Ghani, Reddy, Kanamata, Chen, Hanyong, Shin, Seung Ho, Ma, Wei-ya, Bode, Ann M, Dong, Zigang
Publicado 2020